Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety
- Guy P. Boudreau
- , Brian M. Grosberg
- , Peter J. McAllister
- , Richard B. Lipton
- , Dawn C. Buse
Research output: Contribution to journal › Article › peer-review
58
Link opens in a new tab
Scopus
citations